[Federal Register Volume 80, Number 137 (Friday, July 17, 2015)]
[Notices]
[Page 42497]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-17633]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (5 U.S.C. App. 2), announcement is made of an Agency for 
Healthcare Research and Quality (AHRQ) Special Emphasis Panel (SEP) 
meeting on ``AHRQ RFA HS15-001 Patient Safety Learning Laboratories: 
Innovative Design and Development to Improve Healthcare Delivery 
Systems (P30).'' Each SEP meeting will commence in open session before 
closing to the public for the duration of the meeting.

DATES: July 21-22, 2015 (Open on July 21 from 8:00 a.m. to 8:30 a.m. 
and closed for the remainder of the meeting).

ADDRESSES: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, Maryland 20878.

FOR FURTHER INFORMATION CONTACT: Anyone wishing to obtain a roster of 
members, agenda or minutes of the non-confidential portions of this 
meeting should contact: Mrs. Bonnie Campbell, Committee Management 
Officer, Office of Extramural Research, Education and Priority 
Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 
20850, Telephone: (301) 427-1554.
    Agenda items for this meeting are subject to change as priorities 
dictate.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
the Agency for Healthcare Research and Quality (AHRQ), and agree to be 
available, to conduct on an as needed basis, scientific reviews of 
applications for AHRQ support. Individual members of the Panel do not 
attend regularly scheduled meetings and do not serve for fixed terms or 
a long period of time. Rather, they are asked to participate in 
particular review meetings which require their type of expertise.
    Each SEP meeting will commence in open session before closing to 
the public for the duration of the meeting. The SEP meeting referenced 
above will be closed to the public in accordance with the provisions 
set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 
U.S.C. 552b(c)(6). Grant applications for the ``AHRQ RFA HS15-001 
Patient Safety Learning Laboratories: Innovative Design and Development 
to Improve Healthcare Delivery Systems (P30).'' are to be reviewed and 
discussed at this meeting. The grant applications and the discussions 
could disclose confidential trade secrets or commercial property such 
as patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

Sharon B. Arnold,
AHRQ Director.
[FR Doc. 2015-17633 Filed 7-16-15; 8:45 am]
 BILLING CODE 4160-90-P